medRxiv · Mar 31, 2026
Data-driven subtypes of type 2 diabetes mellitus and risk of dementia, stroke, and brain structural changes in the UK Biobank
By Han S, Zhou Y, Sturkenboom MC et al.
AimsType 2 diabetes mellitus (T2DM) increases risks of stroke and dementia, yet these risks vary across individuals. We hypothesized that clinically derived diabetes subtypes contribute to this heterogeneity. We aimed to identify data-driven subtypes using routine clinical features and examine their associations with dementia, stroke, mortality, and brain structure. MethodsK-means clustering was applied to 14,353 UK Biobank participants with prevalent T2DM using age at diagnosis, body mass index, glycated hemoglobin, insulin resistance (triglyceride/HDL ratio), systolic blood pressure, and C-reactive protein. Cox models assessed associations with incident dementia (all-cause, Alzheimers disease [AD], vascular dementia [VaD]), stroke (all-cause, ischemic [IS], intracerebral hemorrhage [ICH]), and mortality. Brain MRI outcomes were analyzed in 779 participants using inverse probability-weighted linear regression. ResultsThree subtypes were identified: severe obesity-related inflammatory diabetes (SOID), mild metabolic diabetes (MMD, reference), and mild age-related hypertension-predominant diabetes (MARD-H). Compared with MMD, SOID showed higher risks of dementia (HR 1.24), VaD (HR 1.42), stroke (HR 1.38), IS (HR 1.48), all-cause mortality (HR 1.59), and cardiovascular death (HR 1.88). MRI showed lower gray matter volume and greater white matter hyperintensity burden in SOID. ConclusionsData-driven subtyping revealed heterogeneity in neurological risk in T2DM, with the obesity-inflammation subtype showing elevated vascular and neuroimaging risk. Research in ContextO_ST_ABSWhat is already known about this subject?C_ST_ABSO_LIData-driven subtypes of type 2 diabetes mellitus using clinical or genetic features have revealed substantial heterogeneity. C_LIO_LIType 2 diabetes mellitus is associated with increased risks of stroke and dementia, particularly vascular dementia, yet it remains unclear whether these neurological outcomes vary across clinically derived type 2 diabetes mellitus subtypes. C_LI What is the key question?O_LIDo type 2 diabetes mellitus subtypes data-derived from routinely measured clinical variables show differential associations with stroke and dementia subtypes, and brain structural measures? C_LI What are the new findings?O_LIThree type 2 diabetes mellitus subtypes were identified in a large population-based cohort using routinely collected data. C_LIO_LISevere obesity-related inflammatory diabetes subtype showed a higher risk of vascular dementia, ischemic stroke, mortality, and greater white matter hyperintensity burden, whereas associations with Alzheimers disease were not observed. C_LI How might this impact clinical practice in the foreseeable future?O_LIClinical subtyping of type 2 diabetes mellitus may help characterize heterogeneity in neurological risk and identify patient groups with disproportionate vulnerability to vascular brain injury, although further validation is required before clinical implementation. C_LI